Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective study
Abstract Background There is currently no established optimal anticoagulation protocol for plasma exchange (PE) in pediatric patients at a high risk of bleeding. Therefore, we aimed to evaluate the efficacy and safety of regional citrate anticoagulation (RCA) and nafamostat mesylate (NM) for PE anti...
Saved in:
| Main Authors: | Dan Peng, Zili Cai, Jie He, Wei Duan, Xinping Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Italian Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13052-025-01954-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
by: Jing Jiao, et al.
Published: (2023-12-01) -
Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study
by: Jiangtao Li, et al.
Published: (2025-12-01) -
Application of regional citrate anticoagulation to patients with hemodialysis at high risk of bleeding
by: WANG Kui, et al.
Published: (2018-01-01) -
Comparative observation of anticoagulant effect of simplified-regional citrate and argatroban in patients with hemodialysis at high risk of bleeding
by: QIU De-jun, et al.
Published: (2020-01-01) -
Observation of the efficacy of long-term citrate anticoagulation in patients with maintenance hemodialysis
by: ZHUANG Feng, et al.
Published: (2020-01-01)